Monday, January 20, 2014

UpdatesPlus-IBD - Jan 2014

The January issue of UpdatesPlus-IBD is now available.  This month we feature:
  • Janssen's investigational biomarker approach to guide the selection of biologics
  • New Humira data
  • AdCom recommendation of vedolizumab and what this may mean to clinical practice
  • Novel biologic approaches including engineered bacteria and colostrum antibodies for local delivery
  • Two first in class pipeline entries
  • Tyrosine kinase inhibition as a novel approach to IBD
If you have yet to receive this 81 slide issue and would like to see the summary of what is included please click here


Post a Comment

<< Home